Table 5 The pCR status of patients according to treatment arms and adjuvant treatments received by the patients.
Arm-A | p value | Arm-B | p value | |||
|---|---|---|---|---|---|---|
pCR | Non-pCR | pCR | Non-pCR | |||
Adjuvant treatment | n (%) | n (%) | 0.32 | n (%) | n (%) | < 0.001 |
AC + Trastuzumab | 0 (0.0) | 2 (8.0) | 0 (0.0) | 0 (0.0) | ||
Trastuzumab | 18 (72.0) | 16 (64.0) | 44 (93.6) | 31 (68.9) | ||
Trastuzumab + Pertuzumab | 7 (28.0) | 5 (20.0) | 3 (6.4) | 2 (4.4) | ||
Trastuzumab emtansin (T-DM1) | 0 (0.0) | 2 (8.0) | 0 (0.0) | 12 (26.7) | ||
